Ascenta Health Ltd. ('Ascenta'), a developer of award-winning natural health products and industry leader in omega-3 fish oil supplements announced today that it signed a $4 million investment agreement with Avrio Ventures.
Ascenta is committed to developing dietary health products that improve lives through optimal wellness and disease prevention. Its omega-3 product line supports cardiovascular health, joint health, and mental health. The company's team of scientists and industry experts has the necessary experience and understanding of consumer health issues to develop pharmaceutical quality, research-based solutions.
"We are very pleased to have Avrio Ventures as an investor," stated Ascenta Founder and President, Marc St. Onge. "Their commitment and leadership in supporting the growth of Canadian-based consumer health and wellness companies will help us with the continued development of our product lines and will accelerate our international market expansion."
"Ascenta has an established market leading brand, synonymous with quality, purity, and health benefits that are backed by strong scientific evidence," said Aki Georgacacos of Avrio Ventures. "Avrio's investment will help drive Ascenta's momentum, expanding its capability to diversify the product line, and fully take advantage of the opportunity to leverage the growing market trend of fish oil as an essential nutrient and a staple supplement. In particular, we expect the upcoming launch of OmegaSmooth, a superior formulation with an outstanding taste profile, to revolutionize consumer perceptions of fish derived omega-3 supplements."
In Canada, Ascenta's NutraSea brand is the category leader amongst branded supplements distributed through more than 2,000 points of sale in the health food, grocery, sports nutrition, and professional channels. In the US its products are sold through some of the country's largest health food retail chains, and in other international markets, the Company is focused on rapidly growing its customer base. Proceeds from the financing agreement with Avrio Ventures will be used to further develop the existing product line as well as support its continued market roll-out across North America and internationally.
Headquartered in Dartmouth, Nova Scotia, Ascenta develops omega-3 supplements for human health under the NutraSea and OmegaSmooth brands. The company also recently launched a line of omega-3 supplements for animal health. The Ascenta brands are sold throughout North America, the UK, India and Taiwan. www.ascentahealth.com.
About Avrio Ventures
Avrio Ventures is a venture capital firm that supports the development of Canadian commercialization and growth-stage industrial bioproducts, nutraceutical ingredients and food technology companies into world-class organizations. www.avrioventures.com.
For more information, please contact
Alexandra Orozco, Director of Marketing
Email: [email protected]